Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis (Q40876711)

24 September 2017

1 reference

title

Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis (English)

1 reference

24 September 2017

K M Murray

1

1 reference

24 September 2017

S L Dahl

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

31

1 reference

24 September 2017

issue

11

1 reference

24 September 2017

page(s)

1335-1338

1 reference

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101111

Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101111

TNF alpha--a pivotal role in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101111

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101111

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101111

10.1177/106002809703101111

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference